184 related articles for article (PubMed ID: 31295336)
1. Vitamin D deficiency is a potential risk factor for lipid Amphotericin B nephrotoxicity.
Ferreira D; de Bragança AC; Volpini RA; Shimizu MHM; Gois PHF; Girardi ACC; Seguro AC; Canale D
PLoS Negl Trop Dis; 2019 Jul; 13(7):e0007567. PubMed ID: 31295336
[TBL] [Abstract][Full Text] [Related]
2. Nephrotoxicity of amphotericin B is attenuated by solubilizing with lipid emulsion.
Dórea EL; Yu L; De Castro I; Campos SB; Ori M; Vaccari EM; Lacaz Cda S; Seguro AC
J Am Soc Nephrol; 1997 Sep; 8(9):1415-22. PubMed ID: 9294833
[TBL] [Abstract][Full Text] [Related]
3. Potassium depletion potentiates amphotericin-B-induced toxicity to renal tubules.
Bernardo JF; Murakami S; Branch RA; Sabra R
Nephron; 1995; 70(2):235-41. PubMed ID: 7566310
[TBL] [Abstract][Full Text] [Related]
4. Comparison of nephrotoxicity associated to different lipid formulations of amphotericin B: a real-life study.
Falci DR; da Rosa FB; Pasqualotto AC
Mycoses; 2015 Feb; 58(2):104-12. PubMed ID: 25590436
[TBL] [Abstract][Full Text] [Related]
5. Vitamin D deficiency aggravates nephrotoxicity, hypertension and dyslipidemia caused by tenofovir: role of oxidative stress and renin-angiotensin system.
Canale D; de Bragança AC; Gonçalves JG; Shimizu MH; Sanches TR; Andrade L; Volpini RA; Seguro AC
PLoS One; 2014; 9(7):e103055. PubMed ID: 25048368
[TBL] [Abstract][Full Text] [Related]
6. Can we decrease amphotericin nephrotoxicity?
Costa S; Nucci M
Curr Opin Crit Care; 2001 Dec; 7(6):379-83. PubMed ID: 11805538
[TBL] [Abstract][Full Text] [Related]
7. Must we really fear toxicity of conventional amphotericin B in oncological patients?
Mayer J; Doubek M; Vorlìcek J
Support Care Cancer; 1999 Jan; 7(1):51-5. PubMed ID: 9926976
[TBL] [Abstract][Full Text] [Related]
8. The evaluation of frequency of nephrotoxicity caused by liposomal amphotericin B.
Kato H; Hagihara M; Yamagishi Y; Shibata Y; Kato Y; Furui T; Watanabe H; Asai N; Koizumi Y; Mikamo H
J Infect Chemother; 2018 Sep; 24(9):725-728. PubMed ID: 29773439
[TBL] [Abstract][Full Text] [Related]
9. A prospective and retrospective analysis of the nephrotoxicity and efficacy of lipid-based amphotericin B formulations.
Cannon JP; Garey KW; Danziger LH
Pharmacotherapy; 2001 Sep; 21(9):1107-14. PubMed ID: 11560200
[TBL] [Abstract][Full Text] [Related]
10. Vitamin D deficiency is a potential risk factor for contrast-induced nephropathy.
Luchi WM; Shimizu MH; Canale D; Gois PH; de Bragança AC; Volpini RA; Girardi AC; Seguro AC
Am J Physiol Regul Integr Comp Physiol; 2015 Aug; 309(3):R215-22. PubMed ID: 26041113
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and Renal Toxicity of Monomeric Amphotericin B in Rats after a Multiple Dose Regimen.
Kang JY; Gao J; Shin DH; Alvarez C; Zhong W; Kwon GS
Pharm Nanotechnol; 2016; 4(1):16-23. PubMed ID: 27774409
[TBL] [Abstract][Full Text] [Related]
12. Low-dose amphotericin B lipid complex vs. conventional amphotericin B for empirical antifungal therapy of neutropenic fever in patients with hematologic malignancies--a randomized, controlled trial.
Subirà M; Martino R; Gómez L; Martí JM; Estany C; Sierra J
Eur J Haematol; 2004 May; 72(5):342-7. PubMed ID: 15059069
[TBL] [Abstract][Full Text] [Related]
13. Impact of liposomal amphotericin B on renal function in critically ill patients with renal function impairment.
Alvarez-Lerma F; Soriano MC; Rodríguez M; Catalán M; Llorente AM; Vidart N; Garitacelaya M; Maraví E; Fernández E; Alvarado F; López M; Alvarez-Sánchez B; Espinosa J; Quintana E;
Rev Esp Quimioter; 2012 Sep; 25(3):206-15. PubMed ID: 22987267
[TBL] [Abstract][Full Text] [Related]
14. A double-blinded, placebo-controlled, multicenter clinical trial of N-acetylcysteine for preventing amphotericin B-induced nephrotoxicity.
Karimzadeh I; Khalili H; Sagheb MM; Farsaei S
Expert Opin Drug Metab Toxicol; 2015; 11(9):1345-55. PubMed ID: 26050706
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and nephrotoxicity of amphotericin B-incorporated poly(ethylene glycol)-block-poly(N-hexyl stearate l-aspartamide) micelles.
Diezi TA; Takemoto JK; Davies NM; Kwon GS
J Pharm Sci; 2011 Jun; 100(6):2064-70. PubMed ID: 21491436
[TBL] [Abstract][Full Text] [Related]
16. Neonatal fluid and electrolytes profile effect on amphotericin B associated nephrotoxicity in neonatal tertiary care unit of Karachi-Pakistan.
Ambreen G; Rehman A; Hussain K; Sohail M; Javed S; Shamim S; Ali U; Ahmad K; Rizvi A
Expert Opin Drug Saf; 2020 Sep; 19(9):1209-1217. PubMed ID: 32544349
[TBL] [Abstract][Full Text] [Related]
17. Effects of vitamin A and vitamin E on attenuation of amphotericin B-induced side effects on kidney and liver of male Wistar rats.
Salehzadeh A; Salehzadeh A; Maghsood AH; Heidarisasan S; Taheri-Azandaryan M; Ghafourikhosroshahi A; Abbasalipourkabir R
Environ Sci Pollut Res Int; 2020 Sep; 27(26):32594-32602. PubMed ID: 32514920
[TBL] [Abstract][Full Text] [Related]
18. Vitamin D deficiency aggravates chronic kidney disease progression after ischemic acute kidney injury.
Gonçalves JG; de Bragança AC; Canale D; Shimizu MH; Sanches TR; Moysés RM; Andrade L; Seguro AC; Volpini RA
PLoS One; 2014; 9(9):e107228. PubMed ID: 25222475
[TBL] [Abstract][Full Text] [Related]
19. Retrospective Cohort Analysis of Liposomal Amphotericin B Nephrotoxicity in Patients with Hematological Malignancies.
Stanzani M; Vianelli N; Cavo M; Maritati A; Morotti M; Lewis RE
Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28607011
[TBL] [Abstract][Full Text] [Related]
20. Low nephrotoxicity of an effective amphotericin B formulation with cationic bilayer fragments.
Lincopan N; Mamizuka EM; Carmona-Ribeiro AM
J Antimicrob Chemother; 2005 May; 55(5):727-34. PubMed ID: 15761070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
